Market Research Report
Global Personalized Medicines Market Size, Status and Forecast 2019-2025
|Published by||QYResearch||Product code||797683|
|Published||Content info||108 Pages
Delivery time: 2-3 business days
|Global Personalized Medicines Market Size, Status and Forecast 2019-2025|
|Published: July 9, 2019||Content info: 108 Pages||
Personalized medicine is tailoring of a treatment to a specific patient i.e. designing medicine treatment on the basis of diagnosis, disease condition, patient history, body physics, and other factors related to patients and diseases. Personalized medicine is also known as precision medicine, stratified medicine, or P4 medicine.
Growing healthcare expenditure levels triggering the need for an effective diagnostic procedure for cancer, growing prevalence of cancer and increasing usage of combination biomarkers for diagnostics are few factors expected to boost market growth.
In 2018, the global Personalized Medicines market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of 9.5% during 2019-2025.
This report focuses on the global Personalized Medicines status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Personalized Medicines development in United States, Europe and China.
The key players covered in this study
Market segment by Type, the product can be split into
Market segment by Application, split into
Market segment by Regions/Countries, this report covers
The study objectives of this report are:
In this study, the years considered to estimate the market size of Personalized Medicines are as follows:
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.